Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zimmer Biomet Holdings Inc (NYSE:ZBH)

117.32
Delayed Data
As of Jun 28
 +1.98 / +1.72%
Today’s Change
88.27
Today|||52-Week Range
123.43
+14.36%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$23.0B

Company Description

Zimmer Biomet Holdings, Inc. designs, develops, manufactures, and markets orthopedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. It also provides other healthcare related services. The company operations through three major geographic segments: America, Europe and Asia Pacific. The Americas segment comprises principally of the U.S. and includes other North, Central and South American markets. The Europe segment comprises principally of Europe and includes the Middle East and African markets. The Asia Pacific segment comprises primarily of Japan and includes other Asian and Pacific markets. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Contact Information

Zimmer Biomet Holdings, Inc.
1800 West Center Street
Warsaw Indiana 46581-0708
P:(574) 267-6131
Investor Relations:
(574) 371-8042

Employees

Shareholders

Other institutional42.80%
Mutual fund holders41.26%
Individual stakeholders13.46%

Top Executives

David C. DvorakPresident, Chief Executive Officer & Director
Robin T. BarneySenior VP-Global Operations & Logistics
Daniel P. FlorinChief Financial Officer & Senior Vice President
David J. KunzVP-Global Quality, Clinical & Regulatory Affairs
Chad F. PhippsSecretary, Senior Vice President & General Counsel